Ultrasensitive SERS Platform With Highly Efficient Enrichment of Analyte for Screening and Diagnosis of Epithelial Ovarian Cancer
RecruitingOBSERVATIONAL
Enrollment
70
Participants
Timeline
Start Date
January 1, 2025
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2030
Conditions
Ovarian Cancer, Epithelial
Interventions
OTHER
No intervention
No intervention
Trial Locations (1)
Unknown
RECRUITING
Anhui Provincal Hospital, Hefei
All Listed Sponsors
lead
Anhui Provincial Hospital
OTHER_GOV
NCT06640348 - Ultrasensitive SERS Platform With Highly Efficient Enrichment of Analyte for Screening and Diagnosis of Epithelial Ovarian Cancer | Biotech Hunter | Biotech Hunter